|
?:authorAffiliation
|
-
[\'Diabetes Department, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.\', \'University of Nottingham Faculty of Medicine and Health Sciences, Nottingham, UK.\', \'Wellcome Trust-MRC Institute of Metabolic Science, NIHR Cambridge Biomedicl Research Centre, Cambridge University Hospitals and University of Cambridge, Cambridge, Cambridgeshire, UK.\', \'Barnard Health, BHR Limited, Hampshire, UK.\', \'Manchester Clinical Trials Unit, University of Manchester, Manchester, UK.\', \'Academic Department of Diabetes and Endocrinology, Portsmouth Hospitals NHS Trust, Portsmouth, UK.\', \'Manchester Centre for Health Economics, Divison of Population Health, University of Manchester, Manchester, UK.\', \'Northenden Group Practice, Manchester, UK.\', \'The Adam Practice, Poole, UK.\', \'Institute of Immunology and Immunotherapy, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK.\', \'Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, UK.\', \'The Ipswich Diabetes Centre and Research Unit, Ipswich Hospital NHS Trust, Suffolk, Ipswich, UK.\', \'Manchester Diabetes Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, UK.\', \'Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.\', \'Manchester Clinical Trials Unit, University of Manchester, Manchester, UK Lalantha.Leelarathna@mft.nhs.uk.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}